Hepatitis E virus infection: Epidemiology and prevention;Hépatite virale E: Épidémiologie et prévention

Gastroenterologie Clinique et Biologique

Volumn 25, Issue 5, 2001, Pages 521-537

  Castera, Laurent ^a   Pawlotsky, Jean Michel ^b  

^a UNIVERSITÉ PARIS 13   (France)

^b HENRI MONDOR HOSPITAL   (France)

Author keywords

Epidemiology; Hepatitis; Hepatitis E virus; Prevention; Seroprevalence

Indexed keywords

HEPATITIS VACCINE;

DISEASE COURSE; DISEASE MARKER; ENDEMIC DISEASE; HEPATITIS E; HUMAN; IMMUNOPROPHYLAXIS; NONHUMAN; PHYSICAL CHEMISTRY; REVIEW; SEROPREVALENCE; VIRUS CHARACTERIZATION; VIRUS TRANSMISSION;

ANIMALS; ANTIBODIES, VIRAL; DISEASE RESERVOIRS; FEMALE; HEPATITIS E; HEPATITIS E VIRUS; HUMANS; MALE; PREGNANCY; VIRAL VACCINES;

EID: 0034899289     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (271)

1. Long-incubation post-transfusion hepatitis without serological evidence of exposure to hepatitis-B virus
2. Transfusion-associated hepatitis not due to viral hepatitis type A or B
3. The discovery of the hepatitis viruses
4. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genuine
5. Evidence for a virus in non-A, non-B hepatitis transmitted via the fecal-oral route
6. Isolation of a cDNA from the virus responsible for enterically transmitted non-A, non-B hepatitis
7. Hepatitis E virus: Identification of type-common epitopes
8. Solid-phase enzyme-linked immunosorbent assay for hepatitis E virus IgG and IgM antibodies utilizing recombinant antigens and synthetic peptides
9. Occurrence and character of a putative causative virus of enterically-transmitted non-A, non-B hepatitis in bile
10. Non-A, non-B epidemic hepatitis: Visualization of virus-like particles in the stool by immune electron microscopy
11. Enterically transmitted non-A, non-B hepatitis: Recovery of virus-like particles from an epidemic in south Delhi and transmission studies in rhesus monkeys
12. Epidemic non-A, non-B hepatitis in Nepal. Recovery of a possible etiologic agent and transmission studies in marmosets
13. Enterically transmitted non-A, non-B hepatitis: Serial passage of disease in cynomolgus macaques and tamarins and recovery of disease- associated 27- to 34-nm virus-like particles
14. Aetiological association of a virus-like particle with enterically transmitted non-A, non-B hepatitis
15. Aetiological agent of enterically transmitted non-A, non-B hepatitis
16. Hepatitis E
17. Epidemiology of hepatitis E virus infection
18. Hepatitis E virus
19. Hepatitis E virus (HEV): Molecular cloning and sequencing of the full-length viral genome
20. Characterization of a prototype strain of hepatitis E virus
21. Isolation and identification of hepatitis E virus in Xinjiang, China
22. Hepatitis E virus in cultivated cells
23. Enterically transmitted non-A, non-B hepatitis: Identification of virus- associated antigen in experimentally infected cynomolgus macaques
24. The in vitro-synthesized RNA from a cDNA clone of hepatitis E virus is infectious
25. Computer-assisted assignment of functional domains in the nonstructural polyprotein of hepatitis E virus: Delineation of an additional group of positive-strand RNA plant and animal viruses
26. Summary of current nomenclature, taxonomy, and classification of various microbial agents. Viral taxonomy
27. Viral taxonomy
28. Taxonomy of the caliciviruses
29. Evidence that the genomic RNA of hepatitis E virus is capped
30. Virus taxonomy-San Diego 1998
31. Hepatitis E virus: From epidemiology to molecular biology
32. Molecular cloning and sequencing of the Mexico isolate of hepatitis E virus (HEV)
33. Sequence and gene structure of the hepatitis E virus isolated from Myanmar
34. Short report: Phylogenetically distinct hepatitis E viruses in Pakistan
35. Phylogenetic analysis of hepatitis E virus isolates from India (1976-1993)
36. An Indian strain of hepatitis E virus (HEV): Cloning, sequence, and expression of structural region and antibody responses in sera from individuals from an area of high-level HEV endemicity
37. Hepatitis E virus in Nepal: Similarities with the Burmese and Indian variants
38. Hepatitis E virus: Complete genome sequence and phylogenetic analysis of a Nepali isolate
39. A new Chinese isolate of hepatitis E virus: Comparison with strains recovered from different geographical regions
40. Partial sequence comparison of eight new Chinese strains of hepatitis E virus suggests the genome sequence is relatively stable
41. Existing variations on the gene structure of hepatitis E virus strains from some regions of China
42. The sequence of hepatitis E virus isolated directly from a single source during an outbreak in China
43. Complete nucleotide sequence of a hepatitis E virus isolated from the Xinjiang epidemic (1986-1988) of China
44. Sequence comparison of the capsid region of hepatitis E viruses isolated from Myanmar and China
45. Characterization of hepatitis E virus (HEV) from Algeria and Chad by partial genome sequence
46. Molecular characterization of a hepatitis E virus isolate from Namibia
47. Identification of a novel hepatitis E virus in Nigeria
48. African strains of hepatitis E virus that are distinct from Asian strains
49. Phylogenetic analysis of hepatitis E virus isolates from Egypt
50. A hepatitis E virus variant from the United States: Molecular characterization and transmission in cynomolgus macaques
51. A novel virus in swine is closely related to the human hepatitis E virus
52. The sequence and phylogenetic analysis of a novel hepatitis E virus isolated from a patient with acute hepatitis reported in the United States
53. Identification of a novel variant of hepatitis E virus in Italy
54. Identification of a novel strain of hepatitis E virus responsible for sporadic acute hepatitis in Taiwan
55. Distribution géographique des génotypes du virus de l'hépatite E
56. Acute viral hepatitis in Saudi Arabia: Seroepidemiological analysis, risk factors, clinical manifestations, and evidence for a sixth hepatitis agent
57. Acute non-A, non-B hepatitis in Kuwait
58. Imported epidemic non-A, non-B hepatitis in Qatar
59. A divergent genotype of hepatitis E virus in Chinese patients with acute hepatitis
60. The complete sequence of hepatitis E virus genotype 4 reveals an alternative strategy for translation of open reading frames 2 and 3
61. 93G, a novel sporadic strain of hepatitis E virus in south china isolated by cell culture
62. Novel hepatitis E virus (HEV) isolates from Europe: Evidence for additional genotypes of HEV
63. Identification of 2 novel isolates of hepatitis E virus in Argentina
64. HEV identified in serum from humans with acute hepatitis and in sewage of animal origin in Spain
65. Identification of a novel variant of hepatitis E virus in Austria: Sequence, phylogenetic and serological analysis
66. Rhesus monkeys infected with hepatitis E virus (HEV) from the former USSR are immune to subsequent challenge with an Indian strain of HEV
67. Cross-challenge studies in rhesus monkeys employing different Indian isolates of hepatitis E virus
68. Enterically-transmitted non-A, non-B hepatitis
69. Variation in course of hepatitis E in experimentally infected cynomolgus monkeys
70. Successful passive and active immunization of cynomolgus monkeys against hepatitis E
71. Preliminary evidence that a trpE-HEV fusion protein protects cynomolgus macaques against challenge with wild-type hepatitis E virus (HEV)
72. Hepatitis E virus transmission to a volunteer
73. Hepatitis E and long-term antibody status
74. Epidemic hepatitis E in Pakistan: Patterns of serologic response and evidence that antibody to hepatitis E virus protects against disease
75. Protracted viremia during acute sporadic hepatitis E virus infection
76. Seroprevalence of antibody to hepatitis E virus among Chinese subjects in Taiwan
77. Study of an epidemic of non-A, non-B hepatitis. Possibility of another human hepatitis virus distinct from posttransfusion non-A, non-B type
78. Incidence and severity of viral hepatitis in pregnancy
79. Etiology of sporadic acute and fulminant non-A, non-B viral hepatitis in north India
80. Fulminant hepatic failure in pregnant women: Acute fatty liver or acute viral hepatitis?
81. Aetiology and prognostic factors in hepatic failure in central India
82. Contribution of HEV and HCV in causing fulminant non-A, non-B hepatitis in western India
83. Role of hepatitis E virus in sporadic cases of acute and fulminant hepatitis in an endemic area (Chad)
84. Etiological role of hepatitis E virus in sporadic fulminant hepatitis
85. Fulminant hepatitis in a tropical population: Clinical course, cause, and early predictors of outcome
86. Hepatitis C and E in non-A non-B fulminant hepatic failure: A polymerase chain reaction and serological study
87. Non-A, non-B fulminant hepatitis is also non-E and non-C
88. Fulminant or subfulminant non-A, non-B viral hepatitis: The role of hepatitis C and E viruses
89. Failure to incriminate hepatitis B, hepatitis C, and hepatitis E viruses in the aetiology of fulminant non-A non-B hepatitis
90. Acute sporadic viral hepatitis in Ethiopia: Causes, risk factors, and effects on pregnancy
91. Viral hepatitis during pregnancy. Severity and effect on gestation
92. Aetiology and outcome of acute viral hepatitis in pregnancy
93. Observations on infectious hepatitis in pregnancy
94. Vertical transmission of hepatitis E virus
95. Hepatitis E virus infection in pregnant rhesus monkeys
96. Viral specificity of hepatitis E virus antigens identified by fluorescent antibody assay using recombinant HEV proteins
97. Expression and diagnostic utility of hepatitis E virus putative structural proteins expressed in insect cells
98. Hepatitis type E in a French population: Detection of anti-HEV by a synthetic peptide-based enzyme-linked immunosorbent assay
99. Serologic identification of hepatitis E virus infections in epidemic and endemic settings
100. Enzyme immunoassay for the detection of antibody to hepatitis E virus based on synthetic peptides
101. IgM and IgG antibodies to hepatitis E virus (HEV) detected by an enzyme immunoassay based on an HEV-specific artificial recombinant mosaic protein
102. Enzyme-linked immunosorbent assay for diagnosis of acute sporadic hepatitis E in Egyptian children
103. Persistent and transient antibody responses to hepatitis E virus detected by western immunoblot using open reading frame 2 and 3 and glutathione S-transferase fusion proteins
104. Seroepidemiological survey of hepatitis E in Hong Kong by recombinant-based enzyme immunoassays
105. Expression of a hepatitis E virus (HEV)-trpE fusion protein containing epitopes recognized by antibodies in sera from human cases and experimentally infected primates
106. ELISA for antibody to hepatitis E virus (HEV) based on complete open- reading frame-2 protein expressed in insect cells: Identification of HEV infection in primates
107. An epidemic outbreak of hepatitis E in Yangon of Myanmar: Antibody assay and animal transmission of the virus
108. Seroepidemiology of water-borne hepatitis in India and evidence for a third enterically-transmitted hepatitis agent
109. Application of two RNA extraction methods prior to amplification of hepatitis E virus nucleic acid by the polymerase chain reaction
110. Comparison of tests for antibody to hepatitis E virus
111. Age-specific prevalence of antibodies to hepatitis A and E viruses in Pune, India, 1982 and 1992
112. Hépatite de type E. Hépatite non A-non B épidémique à transmission entérale
113. Hepatitis E: An overview
114. Waterborne non-A, non-B hepatitis
115. Direct evidence that non-A, non-B hepatitis is a waterborne disease
116. Epidemiology of hepatitis E in China
117. Epidemic transmission of enterically transmitted non-A, non-B hepatitis in Mexico, 1986-1987
118. Detection of hepatitis E virus in raw and treated wastewater with the polymerase chain reaction
119. Faecal excretion of hepatitis E virus
120. Detection of HEV RNA in faeces, by RT-PCR during the epidemics of hepatitis E in India (1976-1995)
121. Viremia, fecal shedding, and IgM and IgG responses in patients with hepatitis E
122. Enteric non-A, non-B hepatitis: Epidemics, animal transmission, and hepatitis E virus detection by the polymerase chain reaction
123. Hepatitis E virus genome in stools of hepatitis patients during large epidemic in north India
124. Detection of hepatitis E virus RNA in stools and serum by reverse transcription-PCR
125. Short report: Polymerase chain reaction detection of hepatitis E virus in north African fecal samples
126. Infectious hepatitis in Delhi (1955-1956): A critical study; epidemiology
127. Epidemiological investigations of an outbreak of infectious hepatitis in Ahmedabad city during 1975-76
128. A large waterborne viral hepatitis E epidemic in Kanpur, India
129. Epidemic non-A, non-B viral hepatitis in Algeria: Strong evidence for its spreading by water
130. A clinical and epidemiological study of an epidemic of non-A non-B hepatitis in Rangoon
131. Hepatitis E: Intrafamilial transmission versus waterborne spread
132. Epidemic hepatitis E: Serological evidence for lack of intrafamilial spread
133. Hepatitis A virus infection in households
134. A person to person hepatitis A outbreak
135. Hepatitis E: Evidence for person-to-person transmission and inability of low dose immune serum globulin from an Indian source to prevent it
136. Antibody to hepatitis E virus in HIV-infected individuals and AIDS patients
137. Association between hepatitis E virus and HIV infection in homosexual men
138. Hepatitis E antibodies and HIV status
139. Hepatitis E virus and HIV infection in homosexual men
140. Prévalence des anticorps sériques anti-virus de l'hépatite E chez les malades infectés par le virus de l'immunodéficience humaine
141. Hepatitis E virus infection in patients from Saudi Arabia with sickle cell anaemia and beta-thalassemia major: Possible transmission by blood transfusion
142. Transmission of hepatitis E virus by transfusion?
143. Hepatitis E virus and posttransfusion hepatitis
144. High prevalence of hepatitis E virus antibody in haemodialysis patients
145. A high hepatitis E virus seroprevalence among renal transplantation and haemophilia patient populations
146. Antibodies to hepatitis E virus among several populations in Greece: Increased prevalence in an hemodialysis unit
147. Hepatitis E virus infection in north-east Italy: Serological study in the open population and groups at risk
148. Seroprevalence of hepatitis E virus in Switzerland
149. Hepatitis E virus infection in a cohort of patients with acute non-A, non-B hepatitis
150. Seroreactivity to hepatitis E virus in areas where the disease is not endemic
151. Hepatitis type E in haly: A seroepidemiological survey
152. Low risk of transmission of hepatitis E virus by large-pool coagulation factor concentrates
153. Hepatitis E virus antibodies among patients with hemophilia, blood donors, and hepatitis patients
154. Hepatitis E virus infection in hemophiliacs
155. Experimental hepatitis E in pregnant rhesus monkeys: Failure to transmit hepatitis E virus (HEV) to offspring and evidence of naturally acquired antibodies to HEV
156. Elevated hepatitis A and E seroprevalence rates in a Texas/Mexico border community
157. Risk factors and prevalence of hepatitis E in German immigrants from the former Soviet Union
158. Hepatitis E among US travelers, 1989-1992
159. Acute hepatitis E by a new isolate acquired in the United States
160. Locally acquired hepatitis E in the Northern Territory of Australia
161. Case report: Role of hepatitis E virus in the etiology of community- acquired non-A, non-B hepatitis in Greece
162. Hépatite virale E aiguë autochtone en Lorraine
163. Une hépatite virale E autochtone en Languedoc-Roussillon
164. Hépatite virale E aiguë en région Poitou-Charentes
165. Nouveau cas d'hépatite aiguë de type E en France
166. Hépatite virale E subfulminante en France
167. Hepatitis E infection in acute sporadic hepatitis in Spain
168. Hepatitis E virus infection in acute hepatitis in Spain
169. Hepatitis E in The Netherlands: Imported and endemic
170. Sporadic acute hepatitis E in the united kingdom: An underdiagnosed phenomenon?
171. Sporadic hepatitis E in Austria
172. Seroepidemiology of hepatitis E in selected Australian populations
173. Prevalence of and risk factors for antibody to hepatitis E virus seroreactivity among blood donors in Northern California
174. Hepatitis E virus infection in eastern India
175. Aetiology of acute sporadic non-A, non-B viral hepatitis in India
176. Common aetiological agent for epidemic and sporadic non-A, non-B hepatitis
177. Acute sporadic non-A, non-B hepatitis in India
178. Spectrum of hepatitis E virus infection in India
179. Short report: Relative risk of hepatitis A and E among foreigners in Nepal
180. Rates of hepatitis E virus infection and disease among adolescents and adults in Kathmandu, Nepal
181. Acute sporadic hepatitis E virus infection in southern China
182. The impact of traveling to endemic areas on the spread of hepatitis E virus infection: Epidemiological and molecular analyses
183. Epidemic and sporadic hepatitis E virus transmission in West Kalimantan (Borneo), Indonesia
184. Etiology of acute non-A, B, C hepatitis in Thai patients: Preliminary study
185. Acute sporadic hepatitis E in Sudanese children: Analysis based on a new western blot assay
186. Threat of hepatitis E virus infection in Somalia during Operation Restore Hope
187. Incidence of sporadic hepatitis E in Ivory Coast based on still problematic serology
188. Etiology of acute sporadic hepatitis in adults in Senegal and Tunisia
189. Sporadic acute hepatitis caused by hepatitis E virus in Egyptian adults
190. Acute sporadic hepatitis E in children living in Cairo, Egypt
191. Acute sporadic hepatitis E in an Egyptian pediatric population
192. Acute sporadic hepatitis E in Kuwait
193. Waterborne epidemics of non-A, non-B viral hepatitis in India
194. Hepatitis E in a U.S. traveler to Mexico
195. Epidemic non-A, non-B hepatitis in patients from Pakistan
196. Detection of long-lasting antibody to hepatitis E virus in a US traveller to Pakistan
197. Hepatitis E virus infection in an immigrant to the United States
198. A small epidemic of enterically transmitted non-A, non-B acute hepatitis
199. Serological evidence for hepatitis E virus infection in Israel
200. Hepatitis E virus infection in soldiers sent to endemic regions
201. Anti-HEV antibodies in acute hepatitis in France
202. Hepatitis E and hepatitis C virus infections among French soldiers with non-A, non-B hepatitis
203. Imported hepatitis E in UK
204. Hepatitis E infection in the UK
205. Hepatitis E virus infections in patients with acute hepatitis non-A-D in Sweden
206. Epidemic and endemic hepatitis in India: Evidence for a non-A, non-B hepatitis virus aetiology
207. An epidemic of non-A, non-B hepatitis in north India
208. Hepatitis E virus: The cause of a waterbourne hepatitis outbreak
209. An epidemic of infectious hepatitis in the kathmandu valley
210. Water-borne hepatitis E virus epidemic in Islamabad, Pakistan: A common source outbreak traced to the malfunction of a modern water treatment plant
211. Epidemiological criteria as indication of non-A, non-B hepatitis in a community
212. Hepatitis E virus in Indonesia
213. A waterborne outbreak of hepatitis E virus transmission in southwestern Vietnam
214. General characteristics of Botkin's disease occurring in Kirgiz Republic of USSR in 1955-1956
215. Clinico-epidemiological characteristics and diagnosis of viral non-A, non-B hepatitis with fecal and oral mechanisms of transmission of the infection
216. Seroepidemiological study of an acute hepatitis E outbreak in Morocco
217. Characterization of an antigen-antibody system associated with epidemic non-A, non-B hepatitis in West Africa and experimental transmission of an infectious agent to primates
218. Unusual features of viral hepatitis in Accra, Ghana
219. Serological studies of an enterically transmitted non-A, non-B hepatitis in Somalia
220. Outbreak of enterically-transmitted hepatitis due to hepatitis A and hepatitis E viruses
221. Enterically transmitted non-A, non-B hepatitis: Mexico
222. Short report: Further evidence for hepatitis E in the Brazilian Amazon
223. An outbreak of enterically transmitted non-A, non-B hepatitis in Pakistan
224. Association of hepatitis E virus with an outbreak of hepatitis at a military training camp in Nepal
225. A cluster of acute hepatitis E infection in United Nations Bangladeshi peacekeepers in Haiti
226. Hépatite aiguë non-A, non-B épidémique: Étude clinique de 38 cas observés au Tchad
227. Outbreak of acute hepatitis E virus infection among military personnel in northern Ethiopia
228. Enterically transmitted non-A, non-B hepatitis: East Africa
229. Outbreak of enterically transmitted non-A, non-B hepatitis among schoolchildren
230. The etiology of acute hepatitis in hospitalized children in Cairo Egypt
231. Hepatitis E: The enterically transmitted non-A, non-B hepatitis
232. Hepatitis E virus infection in pregnancy in Ethiopia
233. Prevalence of hepatitis C and E in a hyperendemic area of viral hepatitis in China
234. Seroepidemiology of hepatitis E virus in the Egyptian Nile Delta
235. Hepatitis E virus in Chile
236. Hepatitis E in Brazil
237. Determination of hepatitis E virus seroprevalence by using recombinant fusion proteins and synthetic peptides
238. Prevalence of antibodies against hepatitis E virus among urban and rural populations in Venezuela
239. Epidemiology of hepatitis E virus infection in Turkey
240. A community prevalence study of antibodies to hepatitis A and E in inner-city London
241. HEV infection in selected Belgian populations
242. A seroprevalence study of hepatitis E in Europe and the Middle East
243. Evaluation of assays for antibody to hepatitis E virus by a serum panel
244. Hepatitis E (HEV) infection: Prevalence of IgG class antibody to endemic versus non-endemic areas
245. Hepatitis E in the United States: A case of «hog fever»?
246. Novel strains of hepatitis E virus identified from humans and other animal species: Is hepatitis E a zoonosis?
247. Detection of hepatitis E virus infections among domestic swine in the Kathmandu Valley of Nepal
248. Prevalence of antibodies to the hepatitis E virus in pigs from countries where hepatitis E is common or is rare in the human population
249. Identity of a novel swine hepatitis E virus in Taiwan forming a monophyletic group with Taiwan isolates of human hepatitis E virus
250. Clinical and epidemiological implications of swine hepatitis E virus infection
251. Serological evidence for swine hepatitis E virus infection in Australian pig herds
252. Genetic and experimental evidence for cross-species infection by swine hepatitis E virus
253. Experimental infection of pigs with the newly identified swine hepatitis E virus (swine HEV), but not with human strains of HEV
254. An experimental infection in lambs by the hepatitis E virus
255. Evidence for widespread infection of wild rats with hepatitis E virus in the United States
256. The possible involvement of rodents in the spread of viral hepatitis E
257. Experimental infection of the laboratory rat with the hepatitis E virus
258. Prevalence of antibody to hepatitis E virus among rodents in the United States
259. Immunoprophylaxis of epidemic non-A non-B hepatitis
260. Role of immune serum globulins in pregnant women during an epidemic of hepatitis E
261. Recombinant vaccine against hepatitis E: Dose response and protection against heterologous challenge
262. Mapping of linear B cell epitopes on open reading frames 2- and 3- encoded proteins of hepatitis E virus using synthetic peptides
263. Human linear B-cell epitopes encoded by the hepatitis E virus include determinants in the RNA-dependent RNA polymerase
264. Epitope mapping in proteins of hepatitis E virus
265. Comparative characterization of antigenic epitopes in the immunodominant region of the protein encoded by open reading frame 3 in Burmese and Mexican strains of hepatitis E virus
266. Immunodominant antigenic regions in a structural protein of the hepatitis E virus
267. Neutralization of different geographic strains of the hepatitis E virus with anti-hepatitis E virus-positive serum samples obtained from different sources
268. Expression, characterization, and immunoreactivities of a soluble hepatitis E virus putative capsid protein species expressed in insect cells
269. A preliminary study on immune response to hepatitis E virus DNA vaccine in mice
270. Role of long-persisting human hepatitis E virus antibodies in protection